| Date | Title | Description | Source |
| 13.03.2024 | Hummingbird Bioscience and Dartmouth's Geisel School of Medi... | SINGAPORE and HANOVER, Germany, March 13, 2024 /PRNewswire/ -- Hummingbird Bioscience and Dartmouth'... | en.prnasia... |
| 06.03.2024 | Hummingbird Bioscience to Present Two Posters on Anti-HER3 a... | Presentations will highlight the broad potential treatment opportunities for its clinical-stage targ... | en.prnasia... |
| 23.10.2023 | Hummingbird Bioscience Announces Positive Phase I Clinical D... | HMBD-001 is Hummingbird Bioscience's proprietary anti-HER3 antibody in Phase I/IIa trials in the UK ... | en.prnasia... |
| 19.10.2023 | Endeavor BioMedicines Enters License Agreement with Hummingb... | Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be develope... | en.prnasia... |
| 21.08.2023 | Hummingbird Bioscience to Present Poster on HMBD-001 Combina... | HOUSTON and SINGAPORE, Aug. 21, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision... | en.prnasia... |
| 27.07.2023 | Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in... | Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patient... | en.prnasia... |
| 29.05.2023 | Hummingbird Bioscience Announces HMBD-002 Trials in Progress... | HMBD-002, a non-depleting, high-affinity anti-VISTA antibody, possesses key design features enabling... | en.prnasia... |
| 15.05.2023 | Hummingbird Bioscience and Merck Enter Collaboration to Eval... | Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to eval... | en.prnasia... |
| 08.05.2023 | Hummingbird Bioscience to Present Preclinical Proof of Conce... | HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ ant... | en.prnasia... |
| 15.03.2023 | Hummingbird Bioscience to Present Two Posters on HER3-Target... | Presentations highlight the robust tumor growth inhibition in preclinical models for its HER3-target... | en.prnasia... |
| 06.03.2023 | Hummingbird Bioscience Exercises Its Option to License the C... | SINGAPORE and LONDON, March 6, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision ... | en.prnasia... |
| 04.01.2023 | Hummingbird Bioscience and Synaffix Enter License Agreement ... | Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies
Synaffix to receiv... | en.prnasia... |
| 07.11.2022 | Hummingbird Bioscience Announces Two HMBD-002 Poster Present... | VISTA blockade with HMBD-002 reprograms tumor associated macrophages and promotes cytotoxic T-cell r... | en.prnasia... |
| 01.11.2022 | Hummingbird Bioscience to Attend the Credit Suisse 31st Annu... | SAN FRANCISCO, HOUSTON and SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-dr... | en.prnasia... |
| 23.09.2022 | Hummingbird Bioscience Holds Opening Ceremony for Singapore ... | SINGAPORE, Sept. 23, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherape... | en.prnasia... |
| 19.09.2022 | Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-... | SINGAPORE, Sept. 19, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherape... | en.prnasia... |
| 15.09.2022 | ClavystBio launches to translate life sciences breakthroughs... | ClavystBio will invest and work with partners to accelerate life sciences commercialisation in Singa... | en.prnasia... |
| 08.09.2022 | Hummingbird Bioscience Announces Trial in Progress Poster Pr... | HMBD-001 is a proprietary anti-HER3 antibody in an ongoing Phase 1 trial targeting multiple solid tu... | en.prnasia... |
| 06.09.2022 | Hummingbird Bioscience to Participate in the Morgan Stanley ... | SAN FRANCISCO, Sept. 6, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biother... | en.prnasia... |
| 09.02.2022 | Hummingbird Bioscience Publishes Preclinical Data Demonstrat... | HOUSTON and SINGAPORE, Feb. 9, 2022 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-s... | en.prnasia... |
| 06.12.2021 | Hummingbird Bioscience Announces First Patient Dosed in Phas... | HOUSTON and SINGAPORE, Dec. 6, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-s... | en.prnasia... |
| 29.11.2021 | Hummingbird Bioscience Appoints Jan Møller Mikkelsen as Chai... | HOUSTON and SINGAPORE, Nov. 29, 2021 /PRNewswire/ -- Hummingbird Bioscience Holdings Limited, an inn... | en.prnasia... |
| 10.11.2021 | Hummingbird Bioscience Announces Trials in Progress Poster P... | HOUSTON, Nov. 10, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech ... | en.prnasia... |
| 07.10.2021 | Hummingbird Bioscience to Present Pre-Clinical Data on Novel... | HOUSTON and SINGAPORE, Oct. 7, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-s... | en.prnasia... |
| 13.09.2021 | Hummingbird Bioscience Announces US FDA Clearance of IND for... | HOUSTON and SINGAPORE, Sept. 13, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical... | en.prnasia... |
| 13.09.2021 | Hummingbird Bioscience Announces US FDA Clearance of IND for... | | prnewswire... |
| 02.08.2021 | Hummingbird Bioscience Announces UK MHRA Approval for First-... | HOUSTON and SINGAPORE, Aug. 2, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-s... | en.prnasia... |
| 02.08.2021 | Hummingbird Bioscience Announces UK MHRA Approval for First-... | | prnewswire... |
| 12.07.2021 | Hummingbird Bioscience and MD Anderson Announce Strategic Re... | HOUSTON and SINGAPORE, July 12, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-... | en.prnasia... |
| 12.07.2021 | Hummingbird Bioscience and MD Anderson Announce Strategic Re... | | prnewswire... |
| 31.05.2021 | Hummingbird Bioscience Announces Publication of Abstract on ... | HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development
HMBD-002 is anticipat... | en.prnasia... |
| 30.05.2021 | Hummingbird Bioscience Announces Publication of Abstract on ... | | prnewswire... |
| 18.05.2021 | Hummingbird Bioscience Raises US$125M in Series C Financing | Hummingbird Bioscience, a Singapore-based clinical-stage biotech company focused on developing preci... | finsmes.co... |
| 18.05.2021 | Hummingbird Bioscience Raises US$125 Million in Series C Fin... | Investment round led by Novo Holdings, joined by a syndicate of international biotech investors
Proc... | en.prnasia... |
| 18.05.2021 | Hummingbird Bioscience : Raises US$125 Million in Series C F... | Investment round led by Novo Holdings, joined by a syndicate of international biotech investors
Proc... | marketscre... |
| 17.05.2021 | Hummingbird Bioscience Raises US$125 Million in Series C Fin... | | prnewswire... |
| 13.05.2021 | To expand or not to expand? Houston researcher weighs in on ... | You built your business from the ground up, patiently finding techniques and products that work, car... | houston.in... |
| 11.05.2021 | Global accelerator announces 5 startups to its Houston cohor... | Five Houston companies have been tapped to participate in a Houston-based, early-stage startup accel... | houston.in... |
| 10.05.2021 | Energy giant makes Houston sole headquarters in massive move | Power player NRG Energy is laser focused on Houston. The Bayou City will be the energy giant's new s... | houston.in... |
| 05.03.2021 | Photos: Here's a sneak peek at The Ion Houston's constructio... | The Ion Houston is expected to open its doors this year, and the building's exterior is close to com... | houston.in... |
| 27.01.2021 | Rice University competition to link veterans with NextSeed i... | Rice University's Business Veterans Association has helped military veteran raise more that $3.5 mil... | houston.in... |
| 28.12.2020 | Editor's Picks: Top 10 Houston startup feature stories of th... | Editor's note: As 2020 comes to a close, InnovationMap is looking back at the year's top stories in ... | houston.in... |
| 22.12.2020 | Here are the top 5 Houston startup venture capital deals in ... | Editor's note: As 2020 comes to a close, InnovationMap is looking back at the year's top stories in ... | houston.in... |
| 14.12.2020 | Hummingbird Bioscience Announces Collaboration with Tempus t... | | prnewswire... |
| 16.11.2020 | Houston organization names 10 most promising life sciences s... | Last week, the Rice Alliance for Technology and Entrepreneurship gathered over 1,000 life science ex... | houston.in... |
| 04.08.2020 | Houston tech companies have raised over $466M so far this ye... | This year might be a wash for a lot of things, but according to a new fundraising report from Housto... | houston.in... |
| 26.05.2020 | Houston startup raises $10M, A&M names TMC campus, and m... | Houston's innovation ecosystem has been booming with news, and it's likely some might have fallen th... | houston.in... |
| 11.05.2020 | Hummingbird Bioscience Raises US$25M in Series B Extension F... | Hummingbird Bioscience, a Singapore-based innovative biotherapeutics company focused on the discover... | finsmes.co... |
| 11.05.2020 | Biotherapeutics startup Hummingbird Bioscience brings its to... | Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases... | techcrunch... |
| 05.12.2019 | Hummingbird Bioscience secures $19m in Mirae Asset-backed Se... | Premium
Hummingbird Bioscience, focused on precision antibody therapeutics, announced that it has ra... | dealstreet... |
| 05.12.2019 | Hummingbird Bioscience Raises US$19M in Series B Financing | Hummingbird Bioscience, a Singapore, Houston, Texas and South San Francisco, California-based biothe... | finsmes.co... |
| 17.09.2019 | Amgen inks discovery deal with Hummingbird; Merck gain... | → Amgen has enlisted Hummingbird Bioscience on a new antibody discovery pact, turning ove... | endpts.com... |
